Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study

Objective: The primary endpoint of the study was to determine the proportion of patients with HIV RNA < 50 copies/mL at 48 weeks. Design: Phase IV, multicentric, open-label, single-arm clinical trial of participants recruited in 2018–2019 to evaluate the efficacy and safety of tenofovir alafenami...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez Stachowski, Javier, Rial Crestelo, David, Moreno Zamora, Ana, Cabello, Noemi, Ryan, Pablo, Espinosa Aguilera, Nuria, Bisbal, Otilia, Vivancos Gallego, Maria Jesus, Nuñez, Maria Jose, Troya, Jesus, Dominguez, Montserrat, Sierra, Julian Olalla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457350/
https://www.ncbi.nlm.nih.gov/pubmed/36078925
http://dx.doi.org/10.3390/jcm11174994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457350/
https://www.ncbi.nlm.nih.gov/pubmed/36078925
http://dx.doi.org/10.3390/jcm11174994

Ejemplares similares